Home Online Features Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom
Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom
Hand-out
Press Releases
SK Life Science, Inc.  
March 20, 2025

Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom

PARAMUS, N.J., March 20, 2025 /PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company developing treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co.,

logo salamanca press

Salamanca Press

email salamanca press
Local & Social